Acadia Pharmaceuticals | ACAD - Operating Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Acadia Pharmaceuticals

Acadia Pharmaceuticals reported $172.05M in Operating Expenses for its fiscal quarter ending in March of 2023.


Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 172.05M 10.51M
ALKERMES ALKS:US USD 335.09M 9.83M
Alnylam Pharmaceuticals ALNY:US USD 469.1M 54.55M
Biogen BIIB:US USD 1.96B 111.2M
BioMarin Pharmaceutical BMRN:US USD 537.07M 24.97M
Bristol-Myers Squibb BMY:US USD 8.24B 1.22B
Cara Therapeutics CARA:US USD 33.82M 753K
Corcept Therapeutics CORT:US USD 90.8M 10.24M
Cytokinetics CYTK:US USD 129.09M 99K
Eisai 4523:JP JPY 171.99B 7.01B
Eli Lilly LLY:US USD 5.47B 600K
Incyte Corp INCY:US USD 783.9M 72.7M
Intercept Pharmaceuticals ICPT:US USD 99.59M 4.35M
Intra Cellular Therapies ITCI:US USD 143.7M 8.42M
J&J JNJ:US USD 25.48B 5.98B
Marinus Pharmaceuticals MRNS:US USD 43.34M 6.17M
Moderna Inc MRNA:US USD 2.23B 1.28B
Neurocrine Biosciences NBIX:US USD 534.6M 226M
Pfizer PFE:US USD 11.5B 7.63B
Prothena PRTA:US USD 58.49M 8.5M
PTC Therapeutics PTCT:US USD 338M 29.76M
Sarepta Therapeutics SRPT:US USD 778.92M 411.08M
Seattle Genetics SGEN:US USD 704.23M 22.08M
Ultragenyx Pharmaceutical RARE:US USD 254.6M 5.62M
Vanda Pharmaceuticals VNDA:US USD 60.49M 2.64M
Vertex Pharmaceuticals VRTX:US USD 1.6B 326.6M